Patented Products 
 Oncology Formulations
  Therapeutic
    
Segments

 Anaesthetics

 Anthelmintic

 Anti Hypertensives

 Anti- Ulcler Agents

 Anti-Asthamatic

 Anti-Diabetic

 Anti-Fungal

 Anti-Histamines

 Anti-Microbials

 Anti-Tussives

 Drugs In Osteoporosis

 Haematinic And Nutritional Supplement

 NSAIDs

 Skeletal Muscle Relaxants

 Oncology API
 Specialty APIs
 Chiral intermediates
Skeletal Muscle Relaxants
Robinaxol Methocarbamol 350mg + Paracetamol 250mg
Robinaxol d Methocarbamol 500mg + Diclofenac Potassium 50mg + Paracetamol 325mg
Robini gel Oleum Lini 1% w/w + Diclofenac Diethylammonium 1.16% w/w + Methyl Salicylatye I.P. 10.00% w/w + Capsaicin 0.025% w/w
Robinax tab Each uncoated tablet contains:Methocarbamol U.S.P. 500 mg
Robiflam Each uncoated tablet contains: Methocarbamol USP 750 mg + Ibuprofen IP 200 mg
Robiflam-400 Eah uncoated tablet contains:Methocarbamol USP 750 mg + Ibuprofen IP 400 mg
Robilid tablet Each uncoated tablet contains: Methocarbamol USP 1gm + Nimesulide 100mg
Robinax inj Each ml. contains Methocarbamol USP 100 mg + Polyethylene Glycol 300 BP 0.5 ml Water for Injection IP q.s.
 

Present

Introduced Patented Products based on NDDS
(Marketed in India and out-Licensed for the Developing Countries)

  

Future

Patents driven by NDDS, Nano and Dendrimers
(To be marketed in India and to be out Licensed to the developed countries)

 
   
© 2001 - 2007 Khandelwal Laboratories Pvt. Ltd. All rights reserved.